Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related FOE
Mid-Afternoon Market Update: Evoke Pharma Drops On Failed Phase 3 EVK-001 Data; ParkerVision Shares Spike Higher
12 Biggest Mid-Day Losers For Monday
Ferro's (FOE) CEO Peter Thomas on Q2 2016 Results - Earnings Call Transcript (Seeking Alpha)
Related ABX
Barrick Gold Missed Estimates; Goldman Reiterates Conviction Buy Rating On Shares
Earnings Scheduled For July 27, 2016
What Can We Learn From The Gold Majors' Largest Mines (Seeking Alpha)

Analysts at Deutsche Bank upgraded Ferro (NYSE: FOE) from “hold” to “buy.” The target price for Ferro is set to $8. Ferro's shares closed at $6.73 yesterday.

Analysts at BMO Capital upgraded Barrick Gold (NYSE: ABX) from “underperform” to “market perform.” The target price for Barrick Gold has been raised from $17 to $18. Barrick Gold's shares closed at $16.81 yesterday.

Analysts at Aegis Capital upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from “hold” to “buy.” The target price for Cubist Pharmaceuticals is set to $70. Cubist's shares closed at $64.80 yesterday.

Analysts at Cantor Fitzgerald upgraded LinkedIn (NYSE: LNKD) from “hold” to “buy” The target price for LinkedIn has been raised from $170 to $250. LinkedIn's shares closed at $213.00 yesterday.

Latest Ratings for FOE

DateFirmActionFromTo
Jan 2016Deutsche BankMaintainsBuy
Jan 2016Seaport Global SecuritiesUpgradesAccumulateBuy
Sep 2015OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for FOE
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CBST + ABX)

View Comments and Join the Discussion!